immpact-international

Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence

CD38 expression on myeloma cells is a important issue affecting the early response to the anti-CD38 antibody daratumumab. Nevertheless, elements affecting CD38 expression in untreated a number of myeloma are usually not totally elucidated. On this research, we discovered that CD38 expression was considerably decrease in myeloma sufferers with the translocation t(11;14)-associated immature plasma cell phenotype, and significantly in these expressing B-cell-associated genes comparable to PAX5 and CD79A. CD138, a consultant marker of plasmacytic differentiation, was additionally considerably decrease in these sufferers, suggesting that CD38 expression could also be related to the differentiation and maturation phases of myeloma cells.
Moreover, the BCL2/BCL2L1 ratio, a response marker of the BCL2 inhibitor venetoclax, was considerably larger in sufferers with the immature phenotype expressing B-cell-associated genes. The BCL2/BCL2L1 ratio and CD38 expression had been considerably negatively correlated. We additionally confirmed that sufferers with translocation t(11;14) expressing B-cell-associated genes had been certainly much less delicate to daratumumab-mediated direct cytotoxicity however extremely delicate to venetoclax therapy in ex vivo assays. Furthermore, all-trans-retinoic acid, which boosts CD38 expression and induces cell differentiation in myeloma cells, diminished B-cell marker expression and the BCL2/BCL2L1 ratio in myeloma cell traces, resulting in diminished efficacy of venetoclax.
Venetoclax particularly induces cell dying in myeloma with t(11;14), though why sufferers with translocation t(11;14) present BCL2 dependence is unclear. These outcomes counsel that BCL2 dependence, in addition to CD38 expression, are deeply related to the differentiation and maturation phases of myeloma cells. This research highlights the significance of analyzing t(11;14) and contemplating cell maturity in myeloma therapy methods.
Key phrases: BCL2; CD38; daratumumab; a number of myeloma; venetoclax.

CD142 performs a key position within the carcinogenesis of gastric adenocarcinoma by inhibiting BCL2-dependent autophagy

CD142 is expressed on the floor of a number of malignant tumors and contributes to varied carcinogenesis. Nevertheless, the position of CD142 within the pathogenesis of GAC stays unclear. This research aimed to analyze the position of CD142 in GAC carcinogenesis. Our outcomes confirmed that CD142 expression was considerably elevated in GAC most cancers tissues, particularly in these with vital invasion or metastasis. The invasion and migration of CD142-positive SNU16 cells had been considerably elevated in contrast with these of CD142-negative cells. Furthermore, CD142 overexpression promoted the invasion and migration of SGC083 cells, however CD142 silencing was opposite. As well as, there was a constructive correlation between CD142 expression of most cancers tissues and serum IL-Eight ranges. CD142 overexpression promotes IL-Eight manufacturing in SGC083 cells.
In vivo evaluation confirmed that the implantation of CD142-positive SNU16 cells promoted the expansion of xenograft tumor and the manufacturing of IL-8. Mechanistically, CD142 silencing not solely inhibited the expression of BCL2 and the interplay between BCL2 and Beclin1, but additionally promoted the autophagic response in SGC083. Moreover, CD142 silencing-induced IL-Eight degradation was recovered by therapy of autophagy inhibitor 3-MA. CD142 can inhibit autophagic cell dying and the autophagic degradation of IL-Eight in GAC, which exerts an efficient impact on GAC carcinogenesis.
immpact-international
immpact-international

The Incidence and Remedy Response of Double Expression of MYC and BCL2 in Sufferers with Diffuse Giant B-Cell Lymphoma: A Systematic Evaluate and Meta-Evaluation

MYC/BCL2 protein co-expression (i.e., double expressor) has been proven to be a unfavorable predictor of consequence in diffuse massive B-cell lymphoma (DLBCL). We aimed to determine the incidence of double expressor standing in sufferers with de novo DLBCL and determine the predictive worth of this biomarker on therapy response by way of systematic evaluate and meta-analysis. PubMed and Embase had been looked for research printed by way of December 2019 that reported proportions of double expressor DLBCL. The pooled proportions of MYC and BCL2 expression, each alone and together, had been computed utilizing the inverse variance technique for calculating weights and by the DerSimonian-Laird technique. The pooled odds ratios (ORs) of full remission (CR) fee had been calculated, and meta-regression evaluation was carried out to discover heterogeneity. Forty-one research (7054 sufferers) had been included.
The pooled incidence of double expressor standing in DLBCL was 23% (95% confidence interval [CI], 20-26%), with an adjusted estimate of 31% (95% CI, 27-36%). Neither MYC/BCL2 protein cutoff values, race, imply, or median age of included sufferers, or total research high quality was a big issue of heterogeneity (p ≥ 0.20). Instances with out double expressor standing demonstrated the next likelihood of CR to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy (OR, 2.69; 95% CI, 1.55-4.67). Our outcomes reaffirm the predictive energy of this essential biomarker.
Key phrases: immunohistochemistry; lymphoma; meta-analysis; systematic evaluate.

Computational research on novel pure inhibitors focusing on BCL2

 

Very best lead compounds and candidate medication with inhibitory impact on BCL2 had been screened from ZINC database, which laid a basis for drug growth and compound enchancment of drug therapy for diffuse massive B-cell lymphoma (DLCBL). Identification of potential BCL2 inhibitors by computer-aided digital screening. Libdock was utilized to 17,931 compounds and the highest 20 had been chosen for additional evaluation. Chosen compounds had been carried out absorption, distribution, metabolism, and excretion (ADME) and toxicity prediction. The binding affinity between the chosen ligands and BCL2 was confirmed by Molecular docking.

 

  • The brand new pure compounds, ZINC00000255131 and ZINC00013298233, had been discovered to bind intently with BCL2. Moreover, all of them scored decrease in ames-induced mutagenicity, rodent carcinogenicity, non-developmental toxicity potential, and cytochrome P4502D6 tolerance. Molecular dynamics simulation reveals that the mixtures of ZINC00000255131 and ZINC00013298233 with BCL2 within the pure surroundings are extra secure.
  • Two new compounds, ZINC00000255131 and ZINC00013298233, had been discovered to be potential inhibitors of BCL2. These compounds have been proved to be secure, which is of nice significance for the event and enchancment of DLCBL medication.

 

Assembling BH3-mimic peptide right into a nanocluster to focus on intracellular Bcl2 in the direction of the apoptosis induction of most cancers cell

Bcl-2, an anti-apoptotic protein, is at all times overexpressed in tumor cells to suppress the pro-apoptotic perform of Bax, thereby prolonging the lifetime of tumor. Nevertheless, BH3 proteins may instantly activate Bax by way of antagonizing Bcl-2 to induce apoptosis in response to the stimulation. Thus, mimicking BH3 proteins with a peptide is a possible technique for anti-cancer remedy. Sadly, medical translation of BH3-mimic peptide is hindered by its inefficacious mobile internalization and proteolysis resistance.
Herein, we translated a BH3-mimic peptide right into a peptide-auric spheroidal nanocluster (BH3-AuNp), during which polymeric BH3-Auric precursors [Au1+-S-BH3]n are in-situ self-assembled on the floor of gold nanoparticles by a one-pot synthesis. Expectedly, this technique may enhance the anti-proteolytic potential and cytomembrane penetrability of the BH3 peptide.
Consequently, BH3-AuNp efficiently induced the apoptosis of two most cancers cell traces by an order of magnitude in comparison with BH3. This therapeutic and possible peptide nano-engineering technique will assist peptides overcome the pharmaceutical obstacles, awaken its organic capabilities, and probably revive the analysis about peptide-derived nanomedicine.

Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-10ug

QP6168-ec-10ug 10ug
EUR 240

Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-200ug

QP6168-ec-200ug 200ug
EUR 760.8

Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-500ug

QP6168-ec-500ug 500ug
EUR 1272

Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-50ug

QP6168-ec-50ug 50ug
EUR 315.6

Argininosuccinate Lyase (Recombinant)

20-abx073248
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Cystathionine β-lyase, Recombinant

NATE-1146 100mg
EUR 712.8

Recombinant human Selenocysteine lyase

P2183 100ug Ask for price
Description: Recombinant protein for human Selenocysteine lyase

Selenocysteine Lyase Recombinant Protein

92-018 0.05 mg
EUR 852.9
Description: Selenocysteine Lyase belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family. Selenocysteine Lyase exists as a homodimer in the cytosol. In the brain, Selenocysteine Lyase is as an enzyme that putatively salvages Sec and recycles the selenium for selenoprotein translation. Selenocysteine Lyase catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium. Selenocysteine Lyase can be up-regulated In acute glomerulonephritis, it can also be regulated by JUN/AP-1.

HMGCL 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein

PROTP35914 Regular: 20ug
EUR 380.4
Description: HMGCL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 323 amino acids (28-325) and having a molecular mass of 34.2kDa.;HMGCL is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Cystathionine Gamma Lyase (CSE)

4-RPB538Hu01
  • EUR 625.34
  • EUR 290.40
  • EUR 2015.04
  • EUR 751.68
  • EUR 1383.36
  • EUR 494.40
  • EUR 4857.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Cystathionine Gamma Lyase expressed in: E.coli

Recombinant Cystathionine Gamma Lyase (CSE)

4-RPB538Mu01
  • EUR 633.95
  • EUR 292.80
  • EUR 2047.30
  • EUR 762.43
  • EUR 1404.86
  • EUR 499.20
  • EUR 4938.24
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Cystathionine Gamma Lyase expressed in: E.coli

Recombinant Cystathionine Gamma Lyase (CSE)

4-RPB538Ra01
  • EUR 636.10
  • EUR 294.00
  • EUR 2055.36
  • EUR 765.12
  • EUR 1410.24
  • EUR 501.60
  • EUR 4958.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Cystathionine Gamma Lyase expressed in: E.coli

Recombinant E.Coli N-Acetylneuraminate Lyase

7-03193 5µg Ask for price

Recombinant E.Coli N-Acetylneuraminate Lyase

7-03194 20µg Ask for price

Recombinant E.Coli N-Acetylneuraminate Lyase

7-03195 1mg Ask for price

E.Coli N-Acetylneuraminate Lyase (Recombinant)

20-abx073216
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Homocysteine ?,?-Lyase (rHCYase), Active, Recombinant

P1117-200 each
EUR 510

N-acetylneuraminate Pyruvate Lyase (Recombinant)

20-abx073214
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Recombinant Human Cystathionine γ-Lyase/CTH

CF60-10ug 10ug
EUR 175.2
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH

CF60-1mg 1mg
EUR 2739.6
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH

CF60-500ug 500ug
EUR 1935.6
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH

CF60-50ug 50ug
EUR 406.8
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

ATP citrate lyase recombinant monoclonal antibody

A5181 100ul X 3
EUR 714
Description: A recombinant monoclonal antibody from rabbit against human ATP citrate lyase for WB,ELISA

L-Methionine ?-Lyase, Pseudomonas putida recombinant

7848-100 each
EUR 189.6

L-Methionine ?-Lyase, Pseudomonas putida recombinant

7848-500 each
EUR 464.4

HMGCL Human, 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein, Sf9

PROTP35914-1 Regular: 10ug
EUR 380.4
Description: HMGCL Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 305 amino acids (28-325 a.a.) and having a molecular mass of 32.5kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). HMGCL is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

ASL Argininosuccinate Lyase Human Recombinant Protein

PROTP04424 Regular: 20ug
EUR 380.4
Description: ASL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 484 amino acids (1-464) and having a molecular mass of 53.8kDa.;ASL is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

ADSL Adenylosuccinate Lyase Human Recombinant Protein

PROTP30566 Regular: 20ug
EUR 380.4
Description: ADSL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 520 amino acids (1-484) and having a molecular mass of 59kDa.;ADSL is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Sphingosine 1 Phosphate Lyase 1 (SGPL1)

4-RPE691Hu01
  • EUR 560.83
  • EUR 273.60
  • EUR 1773.12
  • EUR 671.04
  • EUR 1222.08
  • EUR 451.20
  • EUR 4252.80
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Sphingosine 1 Phosphate Lyase 1 expressed in: E.coli

Recombinant Sphingosine 1 Phosphate Lyase 1 (SGPL1)

4-RPE691Mu01
  • EUR 603.84
  • EUR 285.60
  • EUR 1934.40
  • EUR 724.80
  • EUR 1329.60
  • EUR 480.00
  • EUR 4656.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Sphingosine 1 Phosphate Lyase 1 expressed in: E.coli

Recombinant Human N-acetylneuraminate Pyruvate Lyase

7-03232 5µg Ask for price

Recombinant Human N-acetylneuraminate Pyruvate Lyase

7-03233 20µg Ask for price

Recombinant Human N-acetylneuraminate Pyruvate Lyase

7-03234 1mg Ask for price

Recombinant Human Selenocysteine Lyase/SCLY (N-6His)

CE52-10ug 10ug
EUR 242.4
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0.

Recombinant Human Selenocysteine Lyase/SCLY (N-6His)

CE52-1mg 1mg
EUR 2739.6
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0.

Recombinant Human Selenocysteine Lyase/SCLY (N-6His)

CE52-500ug 500ug
EUR 1935.6
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0.

Recombinant Human Selenocysteine Lyase/SCLY (N-6His)

CE52-50ug 50ug
EUR 595.2
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0.

Hyaluronate Lyase from Streptococcus pyogenes, recombinant

NATE-0346 10mg
EUR 440.4

Recombinant 2-Hydroxyacyl Coenzyme A Lyase 1 (HACL1)

4-RPG361Hu01
  • EUR 603.84
  • EUR 285.60
  • EUR 1934.40
  • EUR 724.80
  • EUR 1329.60
  • EUR 480.00
  • EUR 4656.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human 2-Hydroxyacyl Coenzyme A Lyase 1 expressed in: E.coli

NANA N-Acetylneuraminate Lyase E.Coli Recombinant Protein

PROTP0A6L4 Regular: 20ug
EUR 380.4
Description: NANA produced in E.Coli is a single, non-glycosylated polypeptide chain containing 317 amino acids (1-297 a.a.) and having a molecular mass of 34.7kDa.;NANA is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Cysteine Conjugate Beta Lyase, Cytoplasmic (CCbL1)

4-RPD863Hu01
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Cysteine Conjugate Beta Lyase, Cytoplasmic expressed in: E.coli

L-Methionine γ-Lyase from Pseudomonas putida, Recombinant

NATE-1655 50u
EUR 712.8

NPL N-acetylneuraminate Pyruvate Lyase Human Recombinant Protein

PROTQ9BXD5 Regular: 20ug
EUR 380.4
Description: NPL produced in E.Coli is a single, non-glycosylated polypeptide chain containing 340 amino acids (1-320 a.a.) and having a molecular mass of 37.3kDa.;NPL is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-1mg

QP6448-ec-1mg 1mg
EUR 1958.4

Recombinant E.coli Yersinia Pestis F1 capsule antigen (caf1) (

YSP31-R-100 100 ug
EUR 416.4

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-1mg

QP7508-ec-1mg 1mg
EUR 2763.6

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-10ug

QP6448-ec-10ug 10ug
EUR 240

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-50ug

QP6448-ec-50ug 50ug
EUR 315.6

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-1mg

QP6448-ye-1mg 1mg
EUR 2763.6

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-100ug

QP6448-ec-100ug 100ug
EUR 489.6

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-200ug

QP6448-ec-200ug 200ug
EUR 760.8

Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-500ug

QP6448-ec-500ug 500ug
EUR 1272

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-10ug

QP6448-ye-10ug 10ug
EUR 326.4

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-50ug

QP6448-ye-50ug 50ug
EUR 424.8

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-100ug

QP7508-ec-100ug 100ug
EUR 848.4

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-10ug

QP7508-ec-10ug 10ug
EUR 391.2

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-200ug

QP7508-ec-200ug 200ug
EUR 1338

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-500ug

QP7508-ec-500ug 500ug
EUR 1816.8

Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-50ug

QP7508-ec-50ug 50ug
EUR 522

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-100ug

QP6448-ye-100ug 100ug
EUR 685.2

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-200ug

QP6448-ye-200ug 200ug
EUR 1077.6

Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-500ug

QP6448-ye-500ug 500ug
EUR 1806

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-1mg

QP6149-ec-1mg 1mg
EUR 2763.6

CCBL1 Cysteine Conjugate-Beta Lyase Cytoplasmic Human Recombinant Protein

PROTQ16773 Regular: 20ug
EUR 380.4
Description: CCBL1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 445 amino acids (1-422 a.a) and having a molecular mass of 50.3kDa. CCBL1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase (HMGCL)

4-RPD685Hu01
  • EUR 464.06
  • EUR 247.20
  • EUR 1410.24
  • EUR 550.08
  • EUR 980.16
  • EUR 386.40
  • EUR 3345.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase expressed in: E.coli

Recombinant 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase (HMGCL)

4-RPD685Mu01
  • EUR 485.57
  • EUR 253.20
  • EUR 1490.88
  • EUR 576.96
  • EUR 1033.92
  • EUR 400.80
  • EUR 3547.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase expressed in: E.coli

anti-2 Hydroxy phytanoyl CoA lyase

YF-PA18196 50 ul
EUR 435.6
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase

anti-2 Hydroxy phytanoyl CoA lyase

YF-PA18197 50 ug
EUR 435.6
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-100ug

QP6149-ec-100ug 100ug
EUR 685.2

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-10ug

QP6149-ec-10ug 10ug
EUR 326.4

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-200ug

QP6149-ec-200ug 200ug
EUR 1077.6

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-500ug

QP6149-ec-500ug 500ug
EUR 1816.8

Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-50ug

QP6149-ec-50ug 50ug
EUR 434.4

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-10ug

QP5607-ec-10ug 10ug
EUR 326.4

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-1mg

QP5607-ec-1mg 1mg
EUR 2763.6

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-50ug

QP5607-ec-50ug 50ug
EUR 434.4

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-100ug

QP5607-ec-100ug 100ug
EUR 685.2

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-200ug

QP5607-ec-200ug 200ug
EUR 1077.6

Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-500ug

QP5607-ec-500ug 500ug
EUR 1816.8

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-1mg

QP5904-ec-1mg 1mg
EUR 1958.4

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, His, E.coli-1mg

QP5905-ec-1mg 1mg
EUR 1958.4

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-100ug

QP5904-ec-100ug 100ug
EUR 489.6

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-10ug

QP5904-ec-10ug 10ug
EUR 240

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-200ug

QP5904-ec-200ug 200ug
EUR 760.8

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-500ug

QP5904-ec-500ug 500ug
EUR 1272

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-50ug

QP5904-ec-50ug 50ug
EUR 315.6

Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, His, E.coli-100ug

QP5905-ec-100ug 100ug
EUR 489.6